INFORMACIÓN BÁSICA SOBRE COOKIES

Una cookie o galleta informática es un pequeño archivo de información que se guarda en su navegador cada vez que visita nuestra página web.
La utilidad de las cookies es guardar el historial de su actividad en nuestra página web, de manera que, cuando la visite nuevamente, ésta pueda identificarle y configurar el contenido de la misma en base a sus hábitos de navegación, identidad y preferencias.
Las cookies pueden ser aceptadas, rechazadas, bloqueadas y borradas, según desee. Ello podrá hacerlo mediante las opciones disponibles en la presente ventana o a través de la configuración de su navegador, según el caso.
En caso de que rechace las cookies no podremos asegurarle el correcto funcionamiento de las distintas funcionalidades de nuestra página web.
Más información en el apartado POLÍTICA DE COOKIES de nuestra página web.

ACEPTAR RECHAZAR

CONGRESSES

Our medical oncologists and laboratory investigators are regular speakers and organizers of some of the most important international seminars and scientific meetings.

We have presented the results of our investigations into the causes of cancer and novel treatments at some of the most important national and international oncology congresses.

BROWSE CONGRESSES
BY YEAR

IASLC 17th World Lung Cancer Congress (WCLC)

DATE04/12/2016 - 07/12/2016

PLACEVienna, Austria

Moving forward in lung cancer: The view after 25 years Rosell R, MD, PhD. Invited lecture.



 

[return] YAP-NOTCH and STAT3 signaling rebound as a compensatory response to gefitinib or osimertinib treatment in EGFR mutant lung cancer Rafael Rosell, Imane Chaib, Niki Karachaliou, Peng Cao, Miguel Angel Molina Vila, Xueting Cai, Ana Drozdowskyj, Jie Yang, Chunping Hu, Andrés F. Cardona, Alex Frías, Chiara Lazzari, Alberto Verlicchi, Jordi Codony Servat, Carles Codony Servat, José Luis Ramírez Serrano, Alain Vergnenegre, Patrick C. Ma, Trever Bivona #4144 Oral

RNA in Lung Cancer
Rosell R, MD, PhD. Invited discussant

Global RET Registry (GLORY) Update: Activity of RET-directed Targeted Therapies in RET-Rearranged Lung Cancers
Oliver Gautschi, Juergen Wolf, Julie Milia, Thomas Filleron, Julien Mazieres, Alexander E. Drilon, on behalf of the GLORY investigators Mini-Oral #4325

Co-activation of STAT3 and YAP1 signaling pathways limits EGFR inhibitor response in lung cancer Niki Karachaliou, Imane Chaib, Andrés F. Cardona, Guillermo López-Vivanco, Alain Vergnenegre, José Miguel Sánchez, Mariano Provencio, Filippo De Marinis, Antonio Passaro, Enric Carcereny, Noemi Reguart, Rosario García Campelo, Mariacarmela Santarpia, Santiago Viteri, Miguel Angel Molina Vila, Xuefei Li, Caicun Zhou, Teresa Morán, José Luis Ramírez Serrano, Trever Bivona, Patrick C. Ma, Ana Drozdowskyj, Peng Cao, Rafael Rosell #4168 Poster

AZD9291 as 1st-line therapy for EGFR mutant NSCLC patients with concomitant pretreatment EGFR T790M mutation. The AZENT study  Niki Karachaliou, Daniela Morales-Espinosa, Miguel Angel Molina Vila, Clara Mayo, Javier Garde, Manuel Cobo, Francisco Baron, Guillermo López-Vivanco, Margarita Majem, José Miguel Sánchez, Santiago Viteri, Aaron Sosa, Irene Moya, Maria González Cao, Maria de los Llanos Gil Moreno, Margarida García, Rafael Rosell #4267 Poster

MET-dependent activation of STAT3 as mediator of resistance  to MEK inhibitors in KRAS-mutant lung cancer Chiara Lazzari, Niki Karachaliou, Alberto Verlicchi, Carles Codony Servat, Ana Gimenez Capitan, Jordi Codony Servat, Jordi Bertrán-Alamillo, Miguel Angel Molina Vila, Imane Chaib, José Luis Ramírez Serrano, Peng Cao, Filippo De Marinis, Vanesa Gregorc, Rafael Rosell #4240 Poster

STAT3 and Src-YAP1 Inhibition Results in Greater Necitumumab Sensitivity in Lung Squamous Cell Carcinoma  Alberto Verlicchi, Niki Karachaliou, Chiara Lazzari, Carles Codony Servat, Ana Gimenez Capitan, Jordi Codony Servat, Jordi Bertrán-Alamillo, Miguel Angel Molina Vila, Imane Chaib, José Luis Ramírez Serrano, Claudio Dazzi, Peng Cao, Rafael Rosell #4242 Poster

The effect of EGF-Pathway Targeted Immunization (EGF PTI) on STAT3 and Cancer Stem Cells in EGFR mutant NSCLC cells Jordi Codony Servat, Miguel Angel Molina-Vila, Jordi Bertrán-Alamillo, Silvia García, Niki Karachaliou, Erik D'Hondt, Rafael Rosell #4698 Poster

SiRe Next Generation Sequencing Panel: Effective Diagnostic Tool for Circulatng Free DNA Analysis  Urnberto Malapelle, Clara Mayo, Danilo Rocco, Monica Garzon, Pasquale Pisapial, Nuria Jordana Ariza, RiccardoSmeraglio, Roberta Sgariglia, Caterina De Luca, Francesco Pepe, Alejandro Martinez-Bueno, Daniela Morales-Espinosa, Maria Gonzilez-Cao, Mild karaohaliou, Santiago Viteri, Claudia Bellevicinel, Christian Rolfo, Miguel Angel Molina Vila, Rafael RosaIl, Giancarlo Troncone #5624 Poster Session

Acquired Resistance to EGFR Tyrosine Kinase Inhibitors (TKIs) in EGFR-Mutant Lung Adenocarcinoma among Hispanics (Rbiop-CLlCaP)    Andrés F Cardona, Oscar Arrieta, Leonardo Rojas, Beatriz WiIIs, Noemí Reguart, Hernan Carranza, Carlos Vargas, Jorge Otero, Pilar Archila, Claudio Martin, Luis Corrales, Mauricio Cuello, Carlos Ortiz, Sandra Franco, Rafael Rosell    #5955  Poster

Characteristics and Long Term Outcomes of Advanced Pleural Mesothelioma in Latin America (MeSO-CLICaP)     Oscar Arrieta , Andres F. Cardona, Luis Corrales, George Oblitas, Leonardo Rojas, Ludwing Bacon, Claudio Martin, Mauricio Cuello, Luis Mas, Beatriz Wills, Carlos Vargas, Hernan Carranza, Jorge Otero, Maria A. Perez, Lisde Gonzalez, Luis Chirinos, Rafael Rosell   #6265  Poster

Treatment of Malignant Pleural Mesothelioma beyond First-Line among Hispanics (MeSO-CLICaP)    Luis Corrales, Andres F. Cardona, Oscar Arrieta, George Oblitas4, Leonardo Rojas, Ludwing Bacon, Claudio Martin, Beatriz Wine, Mauricio Cuello, Luis Alberto Mas Lopez, Carlos Vargas, Hernan Carranza, Jorge Otero, Maria A. Pere, Lisde Gonzalez, Luis Chirinos, Pilar Archila, Rafael Rosell    #6271  Poster

Profiling Response to Chemotherapy in Malignant Pleural Mesothelioma among Hispanics (MeSO-CLICaP)    Andres F. Cardona, Oscar Arrieta, Leonardo Rojas, Luis Corrales, Beatriz Wills, George Oblitas, Ludwing Bacon, Claudio Martin, Mauricio Cuello, Luis Mas, Carlos Vargas, Hernan Carranzal, Jorge Otero, Maria A. Pere, Lisde Gonzalez, Luis Chirinos, Rafael Rosell    #6319   Poster

Prognostic role of hENT1 and RRM1 in patients with advanced pleural mesothelioma treated with second line gemcitabine based regimens    Andres F. Cardona , Oscar Arrieta, Leonardo Rojas, Luis Corrales, Beatriz Wills, George Oblitas, Ludwing Bacon, Claudio Martina, Mauricio Cuello, Luis Masi, Carlos Vargas, Hernan Carranzal, Jorge Otero, Maria A. Perez, Lisde Gonzalez, Luis Chirinos, Rafael Rosell    #6328  Poster

EGFR amplification and sensitizing mutations correlates with survival from erlotinib in lung adenocarcinoma patients (MutP¬CLICAP)    Andres F. Cardona , Oscar Arrieta, Luis Corrales, Leonardo Rojas, Mauricio Cuello, Claudio Martin, Hernan Carranzal, Carlos Vargas , Rafael Rosell    #6335  Poster

Pem/CBP/Bev Followed by Pem/Bev in Hispanic Patients with NSCLC: Outcomes According to Combined Score of TS, ERCC1 and VEGF Expression   Andres F. Cardona , Leonardo Rojas, Beatriz Wills, Oscar Arrieta, Hernan Carranza, Carlos Vargas , Jorge Otero, Mauricio Cuello, Luis Corrales, Claudio Martin, Carlos Ortiz , Sandra Franco, Rafael Rosell    #6293  Poster
 

Avances diagnósticos y pronósticos en oncología

DATE01/12/2016

PLACEBarcelona, Spain

Seminar organized by Laboratories Echevarne

Biopsia Líquida, nueva herramienta para la monitorización del tratamiento Dr. Santiago Viteri



 

VI Congreso Internacional de Oncología del Interior

DATE25/11/2016 - 26/11/2016

PLACESanta Cruz, Chile

Nuevos consensos en cáncer de pulmón de células no pequeñas Dr. Santiago Viteri

Translocación de RET ALK ROS Dr. Santiago Viteri

Biopsia liquida en cáncer de pulmón Dr. Santiago Viteri

Plenary Session & VIII Educational Symposium of the Spanish Lung Cancer Group

DATE17/11/2016 - 18/11/2016

PLACEMadrid, Spain

Keynote Lecture: Liquid biopsy in lung cancer: could it replace tissue rebiopsy? Rafael Rosell, MD, PhD

25 years later: Crossing new borders in lung cancer: overcoming new challenges Rafael Rosell, MD, PhD

Durvalumab HIV Dr. María González Cao
[return] Different approaches for genomic analysis in lung cancer Miguel Angel Molina, PhD
PIPSEN Dr. Santiago Viteri

1st PMPPC International Conference, Personalized Cancer Medicine in the Age of Aging

DATE10/11/2016

PLACEBadalona, Spain

Predictive biomarkers for immune resistance and combinatory therapies with anti-PD-1 and anti-PDL-1 antibodies Rafael Rosell, MD, PhD